Egypt to produce Chinese COVID-19 vaccines locally

This file photo taken on April 29, 2020 shows an engineer working at the Quality Control Laboratory on an experimental vaccine for the COVID-19 coronavirus at the Sinovac Biotech facilities in Beijing. (AFP)
Short Url
Updated 12 December 2020
Follow

Egypt to produce Chinese COVID-19 vaccines locally

  • Under the agreement with GAVI, 20 million doses of coronavirus vaccine will be provided, most likely from AstraZeneca

CAIRO: Egyptian Minister of Health Hala Zayed confirmed that Egypt has obtained legislative approval to produce the Chinese Sinovac coronavirus vaccine locally.

Zayed said that the country is negotiating with the Chinese company Sinovac to manufacture its vaccine in Egypt.

Contracts for local manufacturing will be signed within days following an agreement on the proposal, she said.

“We are seeking to manufacture the Sinovac vaccine and distribute it to African countries. We have a production line ready and are now negotiating financial matters,” she said.

Zayed said that a vaccine shipment that arrived in Egypt on Thursday is the first of several deliveries, with the vaccine to be offered free under a directive by Egyptian President Abdel Fattah El-Sisi.

Egypt has a contract with the Global Alliance for Vaccines and Immunization (GAVI) to obtain more vaccines, she said.

Priority will be given to medical staff, followed by those with chronic diseases, the minister said.

Under the agreement with GAVI, 20 million doses of coronavirus vaccine will be provided, most likely from AstraZeneca.

On Thursday, Egypt received its first batch of coronavirus vaccine, produced by the Chinese company Sinopharma.

The delivery arrived at Cairo International Airport via the United Arab Emirates.

A website will be launched for those seeking the vaccine with a registration site for individual information.

“We have a cold (supply) chain that can handle 110 million doses of the coronavirus vaccine,” she said.

 


The art of war: fears for masterpieces on loan to Louvre Abu Dhabi

Updated 13 March 2026
Follow

The art of war: fears for masterpieces on loan to Louvre Abu Dhabi

  • UAE paid more than €1 billion to borrow priceless works, but experts in France want them back

PARIS: The Middle East war has raised fears for the safety of priceless masterpieces on loan from France to the Louvre Abu Dhabi, the museum’s only foreign branch.
The Abu Dhabi museum, which opened in 2017, has so far escaped damage from nearly 1,800 Iranian drone and missile strikes launched since the conflict erupted on Feb. 28.
However, concerns are mounting in France. “The works must be removed,” said Didier Selles, who helped broker the original agreement between France and the UAE.
French journal La Tribune de l’Art echoed that alarm. “The Louvre’s works in Abu Dhabi must be secured!” it said.
France’s culture ministry said French authorities were “in close and regular contact with the authorities of the UAE to ensure the protection of the works loaned by France.”
Under the agreement with the UAE, France agreed to provide expertise, lend works of art and organize exhibitions, in return for €1 billion, including €400 million for licensing the use of the Louvre name. The deal was extended in 2021 to 2047 for an additional €165 million.
Works on loan include paintings by Rembrandt and Chardin, Classical statues of Isis, Roman sarcophagi and Islamic masterpieces: such as the Pyxis of Al-Mughira.

A Louvre Abu Dhabi source said the museum was designed to protect collections from both security threats and natural disasters.